Sun Yat-sen University: Spondylarthritis trials

The registry lists 10 Spondylarthritis studies with Sun Yat-sen University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1Phase 4 7No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vunakizumab in Adults with SpondyloarthritisNot yet recruitingNCT06770088Phase 4
• A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing SpondylitisStatus unknownNCT03932006Phase 4
• A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With SpondyloarthritisCompletedNCT02960035Phase 4
• Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up StudyCompletedNCT02915354Phase 4
• Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion ProteinCompletedNCT02364479Phase 4
• To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early ASCompletedNCT02311842
• Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing SpondylitisCompletedNCT01934933Phase 4
• A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing SpondylitisCompletedNCT01709656Not applicable
• Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF TherapyCompletedNCT01517620Phase 4
• Clinical Study of Tripterygium Capsule to Treat Early Ankylosing SpondylitisStatus unknownNCT00889694Phase 2/3